KBC
RMD icon

Key Bridge Compliance’s ResMed RMD Stock Holding History

Key Bridge Compliance’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$2.49M Buy
+16,825
New +$3.04M 0.78% 36

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Key Bridge Compliance's RMD Position: Q3 2023 in Review

Key Bridge Compliance opened a new position in ResMed (RMD) in Q3 2023: 16,825 shares worth $2.49M. The stake represents 0.78% of the portfolio and ranks #36 among its holdings.

658 funds tracked by Wall St. Rank hold RMD as of Q3 2023.

  • Key Bridge Compliance held 16,825 shares of ResMed worth $2.49M as of Q3 2023.
  • ResMed was a new Key Bridge Compliance position in Q3 2023.
  • ResMed made up 0.78% of Key Bridge Compliance's portfolio in Q3 2023, its #36 holding.
  • 658 funds tracked by Wall St. Rank held ResMed as of Q3 2023.

Based on Key Bridge Compliance's 13F filing for Q3 2023, filed 13 Oct 2023.